Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

DRUG POLICY ALLIANCE

Filed by DRUG POLICY ALLIANCE.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 17, 2026
Income
Not reported
Expenses
$18,639.00
Filing UUID
cb4ad5b4-956f-4c5e-b394-7c9586a97423
Termination date
Not reported

Expense method: B

Literal source text

Lobbying issues and bill citations

LAW · Law Enforcement/Crime/Criminal Justice

We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).

Literal federal measure citations: H.R. 5068, H.R. 1266, S. 545, H.R. 5415, S. 3076, H.R. 7970

CIV · Civil Rights/Civil Liberties

We urged Congress to support the RESTORE Act (H.R. 5223), a bill that would end the SNAP drug felony ban. We urged Congress to repeal the Thurmond Amendment to end housing discrimination via a bill called the Fair Future Act (H.R. 7765).

Literal federal measure citations: H.R. 5223, H.R. 7765

HCR · Health Issues

We urged Congress to fully fund health programs that support people struggling with addiction in Congressional spending bills (LHHS FY27 appropriations bills). We opposed the inclusion of a rider to ban overdose prevention centers in Congressional spending bills.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.